These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 6721988

  • 1. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission.
    Gatti G, Perucca E, Frigo GM, Notarangelo LD, Barberis L, Martini A.
    Br J Clin Pharmacol; 1984 Apr; 17(4):423-31. PubMed ID: 6721988
    [Abstract] [Full Text] [Related]

  • 2. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML, Assael BM, Appiani AC, Edefonti A, Jusko WJ.
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of prednisolone in children with the nephrotic syndrome.
    Rostin M, Barthe P, Houin G, Alvinerie M, Bouissou F.
    Pediatr Nephrol; 1990 Sep; 4(5):470-3. PubMed ID: 2242307
    [Abstract] [Full Text] [Related]

  • 4. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
    Frey FJ, Frey BM.
    Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
    [Abstract] [Full Text] [Related]

  • 5. Effect of inflammatory bowel disease on absorption and disposition of prednisolone.
    Milsap RL, George DE, Szefler SJ, Murray KA, Lebenthal E, Jusko WJ.
    Dig Dis Sci; 1983 Feb; 28(2):161-8. PubMed ID: 6825536
    [Abstract] [Full Text] [Related]

  • 6. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
    Powell LW, Axelsen E.
    Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
    [Abstract] [Full Text] [Related]

  • 7. Dose dependent pharmacokinetics of prednisone and prednisolone in man.
    Rose JQ, Yurchak AM, Jusko WJ.
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):389-417. PubMed ID: 7310640
    [Abstract] [Full Text] [Related]

  • 8. Corticosteroid pharmacokinetics in liver disease.
    Uribe M, Go VL.
    Clin Pharmacokinet; 1979 Aug; 4(3):233-40. PubMed ID: 383357
    [Abstract] [Full Text] [Related]

  • 9. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
    Schalm SW, Summerskill WH, Go VL.
    Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.
    Unadkat JD, Rowland M.
    Drug Metab Dispos; 1985 May; 13(4):503-9. PubMed ID: 2863117
    [Abstract] [Full Text] [Related]

  • 11. Monitoring prednisone and prednisolone.
    Jusko WJ, Rose JQ.
    Ther Drug Monit; 1980 May; 2(2):169-76. PubMed ID: 6762710
    [Abstract] [Full Text] [Related]

  • 12. Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity.
    Green OC, Winter RJ, Kawahara FS, Phillips LS, Lewy PR, Hart RL, Pachman LM.
    J Pediatr; 1978 Aug; 93(2):299-303. PubMed ID: 671172
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone.
    Frey BM, Schaad HJ, Frey FJ.
    Eur J Clin Pharmacol; 1984 Aug; 26(4):505-11. PubMed ID: 6734709
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.
    Shibasaki H, Nakayama H, Furuta T, Kasuya Y, Tsuchiya M, Soejima A, Yamada A, Nagasawa T.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul 15; 870(2):164-9. PubMed ID: 18387858
    [Abstract] [Full Text] [Related]

  • 15. Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to beagle dogs.
    Colburn WA, Sibley CR, Buller RH.
    J Pharm Sci; 1976 Jul 15; 65(7):997-1001. PubMed ID: 957135
    [Abstract] [Full Text] [Related]

  • 16. Representation and quantitation of the binding interaction between prednisone, prednisolone and corticosteroid binding globulin.
    Unadkat JD, Rowland M.
    J Pharm Pharmacol; 1984 Sep 15; 36(9):582-5. PubMed ID: 6149280
    [Abstract] [Full Text] [Related]

  • 17. The nonlinear pharmacokinetics of prednisone and prednisolone. II. Plasma protein binding of prednisone and prednisolone in rabbit and human plasma.
    Ferry JJ, Wagner JG.
    Biopharm Drug Dispos; 1987 Sep 15; 8(3):261-72. PubMed ID: 3593903
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of intravenous methylprednisolone and oral prednisone in paediatric patients with inflammatory bowel disease during the acute phase and in remission.
    Faure C, André J, Pelatan C, Munck A, Giraud M, Cèzard JP, Jacqz-Aigrain E.
    Eur J Clin Pharmacol; 1998 Sep 15; 54(7):555-60. PubMed ID: 9832298
    [Abstract] [Full Text] [Related]

  • 19. Concurrent administration of antacids and prednisone: effect on serum levels of prednisolone.
    Tanner AR, Caffin JA, Halliday JW, Powell LW.
    Br J Clin Pharmacol; 1979 Apr 15; 7(4):397-400. PubMed ID: 444359
    [Abstract] [Full Text] [Related]

  • 20. Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.
    Madsbad S, Bjerregaard B, Henriksen JH, Juhl E, Kehlet H.
    Gut; 1980 Jan 15; 21(1):52-6. PubMed ID: 7364321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.